key: cord-0794725-b7nk56ny authors: Bersano, Anna; Kraemer, Markus; Touzé, Emmanuel; Weber, Ralph; Alamowitch, Sonia; Sibon, Igor; Pantoni, Leonardo title: Stroke care during the Covid‐19 pandemic: Experience from three large European countries date: 2020-06-03 journal: Eur J Neurol DOI: 10.1111/ene.14375 sha: 7d0b3e0e3556429b9118b34d15976df783b29c1d doc_id: 794725 cord_uid: b7nk56ny To cope with the exponentially increasing number of patients infected by SARS‐Cov‐2, European countries carried out enormous efforts to reorganize medical assistance, and several diseases, including stroke, were particularly impacted. Herein, we report the experience of stroke neurologists from three European countries, Italy, France and Germany, that faced the pandemic at diverse time points and with different approaches, depending on their resources and health care system organization. Pre‐hospital and in‐hospital acute stroke pathways were reorganized to prioritize COVID‐19 management, and, in severely affected regions of Italy and France, stroke care was centralized to a limited number of centers while remaining stroke units were dedicated to COVID‐19 patients. The access to acute stroke diagnostics and time dependent therapies was limited or delayed because of reduced capacities of emergency services due to the burden of COVID‐19 patients. A marked reduction in the number of patients presenting with TIA and stroke was noted in the emergency departments of all three countries. Although we have only preliminary data, overall these conditions may have affected stroke outcome. These indirect effects of COVID‐19 pandemic could vanish the last years' efforts of stroke neurologists to improve outcome and reduce mortality of stroke patients. Although SARS‐Cov‐2 infection rate is slowing down in Europe, the effects of the ending lockdown in the next months are unpredictable. It is important for the European and world stroke community to share the experience learned so far to prepare for the next future and upcoming challenging times in the care of stroke patients. This article is protected by copyright. All rights reserved On May 21, 2020, the spread of the SARS-Cov-2 disease (COVID-19) has reached pandemic proportion, affecting more than 5,011,000 people worldwide 1 . Although the majority of cases were firstly reported in China, Europe became soon thereafter the disease epicenter with Spain and Italy leading the list of countries with the highest number of COVID-19 cases, followed by France and Germany 1 . Since the beginning of the outbreak, European countries have adopted unprecedented measures such as large-scale application of social isolation, closing borders, and nationwide lockdown at great economic cost. In addition, some extreme health care re-organizations have been implemented in several countries to fight against COVID-19, with different time-lag and approaches, also in relation to national health care system organization and resources 2, 3 . The impellent turning of health staff and hospital resources towards COVID-19 emergency is inevitably leading to a serious impairment of the normal medical care, particularly for diseases such as stroke, that is the second cause of death and the first of disability 4 . On the other hand, patients affected by have been hypothesized to be at increased risk of cerebrovascular events, probably due to the infection itself but also thrombotic complications [5] [6] [7] . A third element to be possibly considered is that patients with cerebrovascular diseases might also be at major risk of developing severe consequences from COVID-19 infections 8 . Herein, we report the experience and issues faced in stroke care organization in three European countries (Italy, France, Germany) during the COVID-19 pandemic. Although as of today, the spreading curve of infection is slowly flattening, the COVID-19 pandemic is persisting also in light of the lockdown end. Reporting these experiences and highlighting problems may offer arguments for discussion and for the development of potential strategies to ensure the adequate care of acute or chronic stroke patients in present and future challenging times. Beginning in mid-February 2020, the Italian authorities, particularly the regional health services, which have in Italy considerable autonomy from the central government on health care issues, had to manage a huge reorganization to direct resources towards COVID-19 patient care 9 This article is protected by copyright. All rights reserved accounted in pre-COVID era to about 5100, with an occupation rate of 48.4%, became almost completely dedicated to COVID-19 patients. New ICUs were created, increasing the number of ICU beds up to 8.800 10 . Protective measures, including indications for personnel protection equipment (PPE) and swab testing, were also progressively released according to regional indications. Many regions such as Lombardia, which is, with >10 million inhabitants, the largest in Italy, but also the one with the highest number of COVID-19 cases, decided to dedicate entire hospitals to the increasing need of COVID-19 positive patients. In contrast, the care of other non-COVID diseases as well as non-urgent interventions and outpatient activities were highly reduced or even stopped 11-13. Acute stroke pathways were also completely re-drawn: pre-hospital transportations were reorganized to prioritize the SARS-CoV-2 infected patients' needs; specific triage protocols were activated to assess and manage COVID-19 suspicion or infection. Many stroke units were closed to reallocate stroke physicians and nurses to the care of COVID-19 patients, or were even converted into COVID-19 positive wards 9, 13-14 . Therefore, the usual hub and spoke system underwent an upheaval and all patients started to be primarily directed towards a limited number of centers where they were supposed to remain until discharge 11, [13] [14] . The result of this measure was to concentrate many stroke patients from huge areas in a limited number of hospitals, in relation to regional location and beds and thrombectomy equipment availability. The Lombardia region recognized 11 stroke centers from the previous regional certified 36 stroke units. In the remaining centers, stroke management was limited to emergency care and patients were hospitalized in non-stroke unit beds intermingled with other patients. In hub centers, dedicated areas for non-COVID-19 and COVID-19 positive patients were organized and adequate isolation measures for COVID-19 positive patients treated in stroke units were implemented. However, it was difficult to completely separated pathways due to a considerable number of stroke patients identified as COVID positive in the course of their hospital stay. Therefore, all stroke patients presenting to the emergency department were finally regarded as possible infectious and were isolated. In addition to the usual CT brain scan and CT angiography, these patients underwent chest X ray or CT scan, an extended biochemistry, and infectious disease physician consultation. In the acute care, the multidisciplinary team was maintained but with consultations highly limited by the physician shortage. In addition, the availability of ancillary examinations such as brain MRI or angiography for stroke patients was hampered by the need of keeping protected diagnostic services and of managing COVID-19 patients. Although this reorganization was accompanied by an effort in increasing the number of beds and the personnel availability in some of these newly defined stroke hub centers, these changes likely influenced the availability of timely reperfusion therapies and emergency pathways for stroke patients [13] [14] [15] . Given the overcrowding of emergency rooms of these centers, the personnel shortage and the need of screening procedures as well as multidisciplinary consultations (i.e., infectious disease physicians, anesthesiologists) modified algorithms for patients presenting with large vessel occlusion were implemented, including also safety measures for the medical team and patients. We have no data yet about the current onset-to-needle time in Italy, but it is likely that it has increased, because of the ambulance and emergency operators' heavy engagement, time required for COVID-19 screening procedures and flooding of emergency rooms with patients with respiratory symptoms [13] [14] [15] [16] . Post stroke rehabilitation pathways were also centralized, due to the need of allocate wards to Periodic follow-up visits, previously planned procedures, as well as rehabilitation services for stroke survivors have been cut down in Italy due to restrictive measures implemented to reduce COVID-19 spreading 9,13 . This raised the question of how to take care of patients that need periodic consultations and/or rehabilitation support. To overcome these limitations, some patients were contacted by phone, and platforms of telemedicine were implemented to allow patients visits, thus avoiding direct contact with operators and waiting rooms [19] [20] [21] . On May 21, 2020 in France 181.700 infections and 28.135 (15.4%) deaths were reported 1 . French Government launched on March 6, the emergency plan called "plan blanc" for hospitals. As a result, many hospital beds and staff were reallocated to patients with This article is protected by copyright. All rights reserved COVID-19 infection or suspected infection. In normal conditions, there are about 5000 ICU beds (with ventilator) in France. Due to the pandemic, the number of beds has rapidly increased up to more about 10.000 beds (of these 7200 dedicated to COVID-19 patients) and this increase had to be particularly important in some areas (multiplied by 2 or 3 in a few weeks). Moreover, routine medical consultations were cancelled. Each hospital had to define its own gradual charge depending on the number of COVID-19 patients admitted. A rapid decrease in admissions for acute stroke was observed in almost all stroke units, including those eligible to recanalization therapies. However, at this stage, there is no systematic investigation available for France 16 . Because the epidemic spreading was heterogeneous across the country, we observed various consequences. The most affected areas in France were the Great East, Paris and its suburbs, and to a less extent the North. In these areas, some The main concerns in France on the management of acute stroke patients were delays in call after first symptoms, potential unavailability of anesthesiologist for patients requiring This article is protected by copyright. All rights reserved mechanical thrombectomy, and delay in brain imaging due to the need of disinfection procedures in contaminated CT rooms. In the post-stroke management, as all routine visits were cancelled. Physicians tried to contact patients by phone or have telemedicine calls. In addition, patients with physical disability, speech disorders or cognitive impairment had difficulties in starting out-hospital rehabilitation due to the low the availability of physiotherapists or speech therapists who had to close their offices. Regarding preventive drugs, the French government has allowed pharmacists to extend the delivery of drugs without the need of a new prescription. Finally, we fortunately observe that a large number of COVID19 patients can be discharged from ICU. However, some patients have pulmonary and sometimes neurological (especially critical illness polyneuropathy and myopathy) and will require rehabilitation services, which may result in less beds available for stroke patients. On the other hand, as non-urgent surgical interventions have been postponed, there may be more post-surgery rehabilitation beds available. Before the SARS-CoV-2 pandemic, there were 28.000 intensive care unit beds with 20.000 ventilator devices across all medical departments available for 83 million German This article is protected by copyright. All rights reserved On April 2, the "Cerebrovascular diseases" commission of the German Society of Neurology stated that acute treatment of stroke patients, secondary prevention and rehabilitation should be performed as "smoothly and optimally" as possible 26 Due to more capacity in rehabilitation clinics and reduced authorization periods by the health insurances, German stroke neurologists observed markedly reduced time intervals for transfer of acute stroke patients from stroke units directly to rehabilitation clinics The current COVID-19 crisis has affected not only directly infected patients, but also has had multiple and profound implications for health care systems worldwide, in particular for patients with cardiovascular and cerebrovascular diseases, the two leading causes of death. In this paper, we reported the impact of the COVID-19 outbreak on stroke care in three different European countries. The three countries faced the pandemic in different time-lags and with diverse organized health care systems. Although our report lacks of systematic data in this exceptional and unpredictable situation, the experience in our three European countries may be helpful to be better prepared in the future for new challenging situations. In all the three countries, the COVID-19 pandemic resulted in an adjustment of the emergency pathways and clinical inpatient and outpatient services 16 . In Italy and France, that were hit harder, and earlier in the case of Italy, compared to Germany, the most important organizational change for patients with cerebrovascular diseases was the centralization of acute stroke treatment in a limited number of hospitals and the partial reallocation of stroke unit beds into intermediate or intensive care beds. Also multidisciplinary team management was limited in the three countries. Another important issue is that, differently to what expected from centralization strategies and from the observed increased risk of stroke in COVID-19 patients, the number of TIA and stroke patients accessing to the emergency pathways was unanimously reported to be highly reduced in comparison to the same period in 2019 in all three countries 6 . This phenomenon was observed in most European countries 16 , as stated by the European Stroke and Neurological Societies reports (i.e., European Stroke Organisation-ESO; World Stroke Organization-WSO; European Academy of Neurology-EAN). The most likely explanation is that patients with mild stroke or TIA stayed at home due to the lockdown measures and general advice not to leave their house since doctors and media campaigns advised the people to limit emergency room visits 13, [28] [29] . Furthermore, in Italy and France older patients from nursing homes or rehabilitation clinics with very severe strokes and high pre-existing disability might also not be hospitalized for the lack of stroke unit or intensive care unit beds. Moreover, due to contact ban and the lack of social contact with relatives, neighbors and friends, symptoms like dysarthria, aphasia, neglect or mild paresis could be under-recognized by the patients themselves. Stroke signs might also not be diagnosed in patients hospitalized for pulmonary symptoms due to COVID-19 protective measures and missing neurological examination. Patients with cerebrovascular risk factors such as hypertension, diabetes, previous cardiovascular and cerebrovascular diseases are at major risk of severe COVID-19 illness and could be hospitalized in ICUs for pulmonary problems, without a diagnosis of stroke. In addition, the access to time dependent stroke therapy has been severely limited or delayed by missing transportation capacities, busy emergency services and CT service due to the burden of COVID-19 patients, mostly in those countries, which could not be prepared in time for the exponentially rising numbers of COVID-19 patients. Finally, outpatient visits in stroke survivors has been highly reduced in France, Italy and Germany, while rehabilitation activities were differently continued. Although several hospitals increasingly started to use telemedicine platform, this kind of assistance might not This article is protected by copyright. All rights reserved be the best solution for the generally old population of patients with stroke and is probably insufficient to take care of the large population of patients with chronic cerebrovascular diseases. Our paper is limited by lack of systematic data on acute stroke treatment and outcome and by the missing information on stroke care organization from other European nations, including Spain, which was amongst the early and severely hit countries. We believe that this contingent 'suspended life' 29 might result in a higher risk of stroke occurrence or recurrence and a lower adherence to secondary prevention and rehabilitation treatments, exposing patients to a higher risk of recurrent cerebrovascular events, increased disability and, last but not least, psychological consequences. This indirect effect of COVID-19 pandemic could vanish the effects of previous successful awareness campaigns designed to emphasize the importance of early presentation in case of acute neurological deficits and the last years´ efforts of stroke neurologists to improve functional outcome and reduce mortality in stroke patients 14 A last important remark is to protect patients but also medical staff from in-hospital COVID-19 infection 4, 30 . Many health professionals were in fact infected and died during the pandemic. A number of protection strategies were applied to prevent transmission of pathogens to health professionals or other hospital patients. Some hospitals were reorganized in COVID positive and COVID free areas to prevent unnoticed virus transmission among patients and health staff and to guarantee that a number of services continue to work. Screening strategies, hospital admission protocols and prevention measures were adopted in different ways according to national or local health policies. Differently from Italy and France, that were among the first infected European countries and suffered also an earlier depletion of stocking masks and personal protective equipments (PPEs), Germany adopted earlier, in the course of nationwide pandemic spreading, swab testing and protection strategies. Whether extensive screening is feasible and applicable to all stroke patients presenting at the emergency room, and whether this will be useful when the lockdown measures will be relaxed in the upcoming weeks, is currently discussed. Systematic screening This article is protected by copyright. All rights reserved procedures may in fact induce delays in admission to stroke unit, need for delays in investigations, other than requiring dedicated pathway and beds (i.e., single-rooms), and waiting rooms. In conclusion, the COVID-19 pandemic resulted in deeply alterations in the acute and followup management of stroke patients. Although the control of infection is very important, it is crucial that stroke physicians are able to continue caring for their patients. As pointed out before, it is important to balance between the demands of a global pandemic with limiting nosocomial virus spreading and optimizing acute care resources, and the maintenance of access to out-and inpatient stroke services 4 . Hospital administrators and health system authorities should be reminded that stroke care is dependent on specialized and multidisciplinary teams and stroke physicians should be not removed from stroke patients' care. Another challenging task for stroke physicians is to make sure care for an ongoing medical and non-medical secondary prevention and rehabilitation therapy in their patients. Political leaders and health authorities should get or stay in close contact with physicians to maintain the best possible treatment of acute and chronic stroke patients by careful planning strategies without forgetting investment in research, education and training 4 . The results from ongoing prospective and retrospective observational studies in stroke patients will be helpful to further direct stroke treatment in this challenging situation. Given the heterogeneous strategies applied in different countries, we highly suggest information and scientific exchanges by using existing and establishment of new national and international stroke networks 16 . Accepted Article This article is protected by copyright. All rights reserved 2. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet Facing Covid-19 in Italy -Ethics, Logistics, and Therapeutics on the Epidemic's Front Line Challenges and Potential Solutions of Stroke Care During the Coronavirus Disease 2019 (COVID-19) Outbreak. Stroke Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature On being a neurologist in Italy at the time of the COVID-19 outbreak Neurology, in press Accepted Article This article is protected by copyright. All rights reserved 10 The response of Milan's Emergency Medical System to the COVID-19 outbreak in Italy Acute stroke management pathway during Coronavirus-19 pandemic No lockdown for neurological diseases during COVID19 pandemic infection Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From EXPRESS: COVID-19 and Stroke -A Global World Stroke Organisation perspective Video consultations for covid-19 Virtually Perfect? Telemedicine for Covid-19 The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological Disorders Accepted Article This article is protected by copyright. All rights reserved 22 Corona-Virus: Fakten und Infos. Deutsche Krankenhaus Deutsche-Interdisziplinäre-Vereinigung-für-Intensiv-und-Notfallmedizin-e.V. (2020) Intensivregister -Öffentlich Aktuelle Belegungssituation intensivmedizinischer Bereiche der Krankenhaus-Standorte Deutschlands Accessed Täglicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19)-AKTUALISIERTER STAND FÜR DEUTSCHLAND Robert-Koch-Institut. Accessed Aktuelle Informationen zur SARS-CoV-2-Pandemie Impact of Coronavirus Disease 2019 (COVID-19) Outbreak o ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China. Circ Cardiovasc Qual Outcomes Perspective: cardiovascular disease and the Covid-19 pandemic Hyperacute Stroke Management During the Coronavirus Disease Accepted Article Sciences. He has no financial disclosure. Data sharing is not applicable to this article as no new data were created or analyzed in this study.